Clinical Trial Update: Effect of Bempedoic Acid on Liver Fat in Individuals With Nonalcoholic Fatty Liver Disease and Type 2 Diabetes [NA]

View source ↗

Summary

A clinical trial is investigating whether bempedoic acid can affect liver fat in individuals with nonalcoholic fatty liver disease and type 2 diabetes mellitus,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Nexletol (bempedoic acid)

Snippet

Sponsor: Medanta, The Medicity, India | Conditions: Type 2 Diabetes, Non Alcholic Fatty Liver Disease | NA | Status: RECRUITING